King Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference

2008-08-28 23:13:02 -

www.kingpharm.com - King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live webcast of its presentation scheduled for Wednesday, September 3, 2008, at 9:10 a.m., Eastern Daylight Time, at the Thomas Weisel Partners Healthcare Conference at the Four Seasons Hotel in Boston, Massachusetts. The presentation may include a discussion of the Company's marketed products, pipeline, strategy for growth, strategic

opportunities, financial results and expectations, and other matters relating to its business. Interested persons may access the live webcast via the internet on the King Pharmaceuticals website at www.kingpharm.com/web_casts.asp. A replay of the webcast may be accessed at this same link.

About King Pharmaceuticals, Inc.

King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience, hospital and acute care. King strives to be a leader and partner of choice in bringing innovative, clinically-differentiated medicines and technologies to market.

About Forward-looking Statements

This release contains forward-looking statements which reflect management's current view of future events and operations, including, but not limited to, statements pertaining to the anticipated webcast of the Company's presentation on September 3, 2008. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward-looking statements. An important factor which may cause results to differ is whether King is able to webcast the presentation on September 3, 2008 as currently planned. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.

King Pharmaceuticals, Inc.
James E. Green, 423-989-8125
Executive Vice President, Corporate Affairs
or
David E. Robinson, 423-989-7045
Senior Director, Corporate Affairs